“In Oregon, marijuana is second only to alcohol when it comes to admissions for substance abuse treatment, yet it’s hard to find any targeted programs here or elsewhere,” reports Portland Business Journal writer Elizabeth Hayes. She goes on to describe a study being carried out by CODA Research that is looking at the effects of the drug N-acetylcysteine, or NAC, on marijuana-use abstinence.
More News
The CATT’s Beaverton Site is Open!
Washington County News: On Monday, November 17th, the CATT’s Beaverton Recovery Center (BRC) site officially began admitting individuals into residential treatment and withdrawal management (detox) treatment. This event marked the culmination of six years of …
11/23/2025
CODA Medical Director Weimer in TIME
Melissa Weimer, CODA’s Medical Director, appears in a well-written article in Time magazine, headlined “Stopping America’s Hidden Overdose Crisis.” As Time writer Jon Marcus observes, “Weimer is an advocate of sharing prescription information across state …
9/17/2014
12 steps in Iran: How AA is changing society and health
The New York Times takes a fascinating look at the emergence of Alcoholics Anonymous in Iran. Moving from a culture in which beatings are the go-to approach for substance use disorders involving alcohol, a new …
CODA’s recognition for quality and safety
CODA’s Portland Recovery Center is now the only medication-assisted treatment program in Portland to have earned the The Joint Commission’s Gold Seal of Approval®! This accreditation recognizes our dedication to continuous compliance with The Joint …
2/15/2013
News,